Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: An analysis of the UNOS database

Archives of Surgery

Volumn 146, Issue 8, 2011, Pages 953-958

  Gedaly, Roberto ^a   Daily, Michael F ^a   Davenport, Daniel ^a   McHugh, Patrick P ^a   Koch, Alvaro ^a   Angulo, Paul ^a   Hundley, Jonathan C ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; CARCINOID; CHILD; COLD ISCHEMIA; CONTROLLED STUDY; DATA BASE; DISTANT METASTASIS; FEMALE; GASTRINOMA; GLUCAGONOMA; HUMAN; INSULINOMA; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE TUMOR; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE; UNIVERSITY HOSPITAL; VASOACTIVE INTESTINAL PEPTIDE SECRETING TUMOR;

ADULT; CHILD; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; NEUROENDOCRINE TUMORS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 80051758316     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.2011.186     Document Type: Article

References (18)

1. Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol. 2007;47(4):460-466. (Pubitemid 47331755)
2. Que FG, Nagorney DM, Batts KP, Linz LJ, Kvols LK. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg. 1995;169(1):36-42.
3. Öberg K, Astrup L, Eriksson B, et al; Nordic NE Tumour Group. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms), part II - specific NE tumour types. Acta Oncol. 2004;43(7):626-636. (Pubitemid 39563935)
4. Sarmiento JM, Heywood G, Rubin J, Ilstrup DM, Nagorney DM, Que FG. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg. 2003;197(1):29-37. (Pubitemid 36759176)
5. Nagorney DM, Atwell TD, Que FG, Blumgart LH, ed. Hepatic metastases from primary neuroendocrine tumors. In: Surgery of the Liver, Biliary Tract, and Pancreas. New York, NY: Saunders Elsevier; 2007:1195-1209 .
6. Grazi GL, Cescon M, Pierangeli F, et al. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology. 2000;47(32):481-486. (Pubitemid 30216319)
7. Nave H, Mössinger E, Feist H, Lang H, Raab H-R. Surgery as primary treatment in patients with liver metastases from carcinoid tumors: a retrospective, unicentric study over 13 years. Surgery. 2001;129(2):170-175.
8. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation. 1998;66(10):1307-1312. (Pubitemid 28551010)
9. Rosenau J, Bahr MJ, von Wasielewski R, et al. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation. 2002;73(3):386-394. (Pubitemid 34174288)
10. Le Treut YP, Delpero JR, Dousset B, et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors: a 31-case French multicentric report. Ann Surg. 1997;225(4):355-364. (Pubitemid 28047214)
11. van Vilsteren FGI, Baskin-Bey ES, Nagorney DM, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl. 2006;12(3):448-456.
12. Arnold R, Simon B, Wied M. Treatment of neuroendocrine GEP tumours with somatostatin analogues: a review. Digestion. 2000;62(suppl 1):84-91. (Pubitemid 30665945)
13. Søreide O, Berstad T, Bakka A, et al. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery. 1992;111(1):48-54.
14. Dousset B, Saint-Marc O, Pitre J, Soubrane O, Houssin D, Chapuis Y. Metastatic endocrine tumors: medical treatment, surgical resection, or liver transplantation. World J Surg. 1996;20(7):908-914.
15. Gedaly R, Shoukouh-Amiri H, Shimizu A, Osama Gaber A, Sylvestre PB, Vera S. Liver transplantation for the treatment of nonresectable metastatic duodenal paraganglioma. Transpl Int. 2006;19(10):848-850. (Pubitemid 44358853)
16. Iwatsuki S, Dvorchik I, Marsh JW, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191(4):389-394.
17. McHugh PP, Gilbert J, Vera S, Koch A, Ranjan D, Gedaly R. Alpha-fetoprotein and tumour size are associated with microvascular invasion in explanted livers of patients undergoing transplantation with hepatocellular carcinoma. HPB (Oxford). 2010;12(1):56-61.
18. Island ER, Pomposelli J, Pomfret EA, Gordon FD, Lewis WD, Jenkins RL. Twenty-year Experience with liver transplantation for hepatocellular carcinoma. Arch Surg. 2005;140(4):353-358. (Pubitemid 40489952)